印度高等法院允许Natco 出售廉价的通用面膜, 拒绝Roche的专利。 India's high court lets Natco sell cheap generic risdiplam, rejecting Roche's patent.

德里高等法院驳回了Roche的上诉, 允许Natco Pharma出售一种用于治疗脊椎肌肉萎缩的稀有病药的普通版本。 The Delhi High Court has dismissed Roche’s appeal, allowing Natco Pharma to sell a generic version of the rare disease drug risdiplam, used to treat spinal muscular atrophy. 以Natco(Natco)的版本价格为每瓶15 900美元, 低于Roche的6.2 lakh — — 这可能有利于在印度罕见疾病基金下进行更广泛的治疗。 The ruling supports affordable access, with Natco’s version priced at ₹15,900 per bottle—down from Roche’s ₹6.2 lakh—potentially enabling broader treatment under India’s rare disease fund. 法院驳回了Roche的专利要求,理由是缺乏实质性创新和优先考虑公共健康。 The court rejected Roche’s patent claims, citing lack of substantial innovation and prioritizing public health. Roche已提出上诉,案件可能提交最高法院。 Roche has appealed, and the case may reach the Supreme Court.